These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11784578)

  • 1. Gaucher's disease. Enzyme therapy is not enough.
    Grabowski GA
    Lancet; 2001 Dec; 358 Suppl():S29. PubMed ID: 11784578
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation in Gaucher's disease: effect of mixed chimeric state.
    Chan KW; Wong LT; Applegarth D; Davidson AG
    Bone Marrow Transplant; 1994 Aug; 14(2):327-30. PubMed ID: 7994251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current therapeutic focus in type I Gaucher's disease].
    Pérez Calvo JI; Pastores GM; Isola L; Giraldo P; Bueno Gómez J
    Sangre (Barc); 1994 Feb; 39(1):39-44. PubMed ID: 8197518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enzyme replacement therapy for Gaucher's Disease].
    Winckler T
    Pharm Unserer Zeit; 2008; 37(5):352-3. PubMed ID: 18729283
    [No Abstract]   [Full Text] [Related]  

  • 5. Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy.
    Perel Y; Bioulac-Sage P; Chateil JF; Trillaud H; Carles J; Lamireau T; Guillard JM
    Pediatrics; 2002 Jun; 109(6):1170-3. PubMed ID: 12042560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gaucher's disease and enzyme replacement therapy].
    Cornu F
    Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gaucher's disease; current developments in the treatment of lysosomal metabolic disease].
    Hollak CE; Aerts JM; Goudsmit R
    Ned Tijdschr Geneeskd; 1991 Nov; 135(46):2162-4. PubMed ID: 1956441
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic approaches to lysosomal storage diseases.
    Kaye EM
    Curr Opin Pediatr; 1995 Dec; 7(6):650-4. PubMed ID: 8776014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement and gene therapy for Gaucher's disease.
    Brady RO; Barton NW
    Lipids; 1996 Mar; 31 Suppl():S137-9. PubMed ID: 8729108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from glucosylceramide and Gaucher's disease.
    Luft FC
    J Mol Med (Berl); 1998 Oct; 76(11):723-4. PubMed ID: 9826117
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary involvement of Gaucher's disease in children: a common presentation in Saudi Arabia.
    Banjar H
    Ann Trop Paediatr; 1998 Mar; 18(1):55-9. PubMed ID: 9692003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher's disease: a brand leader.
    Cox TM
    Lancet; 1993 Sep; 342(8873):694-5. PubMed ID: 8103817
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gaucher's disease--ocular manifestation and treatment].
    Filipek E; Koraszewska-Matuszewska B
    Klin Oczna; 2006; 108(7-9):357-60. PubMed ID: 17290842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher's disease: new hope for treatment.
    Barranger JA
    Lancet; 1993 Nov; 342(8883):1372. PubMed ID: 7901672
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gaucher's disease].
    Hatano Y; Miura AB
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):383-5. PubMed ID: 9851168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher's disease, a review.
    Peters SP; Lee RE; Glew RH
    Medicine (Baltimore); 1977 Sep; 56(5):425-42. PubMed ID: 329054
    [No Abstract]   [Full Text] [Related]  

  • 18. Initiation of enzyme replacement therapy for an adult patient with asymptomatic type 1 Gaucher's disease.
    Tanaka N; Saito H; Ito T; Momose K; Ishida F; Hora K; Kiyosawa K; Ida H
    Intern Med; 2001 Aug; 40(8):716-21. PubMed ID: 11518109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
    Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D
    Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Course of a case of Gaucher's disease type 1 treated over a year with glucocerebrosidase (Cérédase)].
    Belmatoug N; Azorin M; Huten D; de Villemeur TB; Carbon C
    Rev Med Interne; 1993; 14(10):996. PubMed ID: 8009089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.